US Health and Human Services Secretary Alex Azar on Wednesday told CNN’s Alisyn Camerota that he was learning of the allergic reactions experienced by two people in the UK to the Covid-19 vaccine “just with you, right now.”
Camerota asked Azar if he thought it would change anything in the United States, such as a pending emergency use authorization for Pfizer/BioNTech’s vaccine candidate by the US Food and Drug Administration.
Azar said he wanted to make sure the FDA had an opportunity to look at that data, adding he is certain they’ll be speaking with UK regulators, like always.
“FDA is going to not cut any corners,” Azar said. “They’re looking at the data. They’re looking under the hood at everything. So I’m sure that’ll be something the FDA looks at here, because we want to make sure that any vaccine that comes out in America has the full gold-standard stamp of approval of the FDA career people.”
Yesterday: The United Kingdom became the world's first nation to begin vaccinating its citizens with a fully vetted and authorized Covid-19 shot, a landmark moment in the coronavirus pandemic.
The first Briton to get the Pfizer/BioNTech vaccine received the first of two doses Tuesday, less than a week after the UK became the first country to approve it.